VinFuture Laureate Prof. Drucker Sees More Innovation Ahead in GLP-1 Therapies
April 14, 2025 | 22:00
Prof. Daniel Drucker’s pioneering work on GLP-1, in collaboration with world-renowned scientists, has transformed treatment for diabetes and obesity - and is now opening new frontiers in neurodegenerative disease research.
Mobile Version